FDA Backs Pfizer COVID-19 Boosters For Seniors, High-Risk

The FDA has approved a third Pfizer booster dose for Americans over 65 and those at high risk of severe disease or exposure at work. The booster must be administered at least six months after the second shot. However, a CDC panel still needs to recommend the booster, and this is not guaranteed.

What new insight or understanding did you gain from this video?